Literature DB >> 9893744

The normal structure and function of CD44 and its role in neoplasia.

R J Sneath1, D C Mangham.   

Abstract

CD44 is a transmembrane glycoprotein, the variant isoforms of which are coded for by alternative splicing, with the most prolific isoform being CD44 standard. CD44 is found in a wide variety of tissues including the central nervous system, lung, epidermis, liver, and pancreas, whereas variant isoforms of CD44 (CD44v) appear to have a much more restricted distribution. Variants of CD44 are expressed in tissues during development, including embryonic epithelia. Known functions of CD44 are cellular adhesion (aggregation and migration), hyaluronate degradation, lymphocyte activation, lymph node homing, myelopoiesis and lymphopoiesis, angiogenesis, and release of cytokines. The functions of CD44 are principally dependant on cellular adhesion in one setting or another. The role of CD44 in neoplasia is less well defined, although metastatic potential can be conferred on non-metastasising cell lines by transfection with a variant of CD44 and high levels of CD44 are associated with several types of malignant tumours. The physiological functions of CD44 indicate that the molecule could be involved in the metastatic spread of tumours. Many studies have investigated the pattern of CD44 distribution in tumours and some observations suggest that certain cells do not use CD44 in tumorigenesis or in the production of metastases. However, the data are extremely conflicting, and further studies are needed to establish the prognostic value of CD44 and its variant isoforms. The precise function of CD44 in the metastatic process and the degree of involvement in human malignancies has yet to be established fully.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893744      PMCID: PMC395635          DOI: 10.1136/mp.51.4.191

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  107 in total

1.  Mechanism of peripheral T cell activation by coengagement of CD44 and CD2.

Authors:  P Conrad; B L Rothman; K A Kelley; M L Blue
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

Review 2.  Cell surface heparan sulfate proteoglycans.

Authors:  M Yanagishita; V C Hascall
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

Review 3.  The protein and proteoglycan guises of Hermes/CD44.

Authors:  J T Gallagher
Journal:  Glycobiology       Date:  1992-04       Impact factor: 4.313

4.  CD44 is the principal cell surface receptor for hyaluronate.

Authors:  A Aruffo; I Stamenkovic; M Melnick; C B Underhill; B Seed
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  Osteopontin--a possible anchor of osteoclasts to bone.

Authors:  F P Reinholt; K Hultenby; A Oldberg; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

7.  CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.

Authors:  J Lesley; R Hyman
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

8.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

Authors:  R Arch; K Wirth; M Hofmann; H Ponta; S Matzku; P Herrlich; M Zöller
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

Review 9.  CD44: the hyaluronan receptor.

Authors:  C Underhill
Journal:  J Cell Sci       Date:  1992-10       Impact factor: 5.285

10.  Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells.

Authors:  S J Neame; C M Isacke
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  89 in total

1.  FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.

Authors:  Alexandros Garouniatis; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

Review 2.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

3.  Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells.

Authors:  Fatma Aboulnasr; Ashton Krogman; Rondell P Graham; Nathan W Cummins; Anisha Misra; Enrique Garcia-Rivera; Jeff R Anderson; Sekar Natesampillai; Nicole Kogan; Murali Aravamudan; Zilin Nie; Thomas D Y Chung; Richard Buick; Andrew L Feldman; Rebecca L King; Anne J Novak; Stephen M Ansell; Saad Kenderian; Andrew D Badley
Journal:  Clin Cancer Res       Date:  2020-07-15       Impact factor: 12.531

4.  Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.

Authors:  A Tzankov; A-C Pehrs; A Zimpfer; S Ascani; A Lugli; S Pileri; S Dirnhofer
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

5.  Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models.

Authors:  Dan Peer; Rimona Margalit
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

6.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

Review 7.  Molecular mechanisms of metastasis in prostate cancer.

Authors:  Noel W Clarke; Claire A Hart; Mick D Brown
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

Review 8.  Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives.

Authors:  Caterina Fanali; Donatella Lucchetti; Marisa Farina; Maddalena Corbi; Valerio Cufino; Achille Cittadini; Alessandro Sgambato
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

9.  CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.

Authors:  Hidetoshi Mori; Taizo Tomari; Naohiko Koshikawa; Masahiro Kajita; Yoshifumi Itoh; Hiroshi Sato; Hideaki Tojo; Ikuo Yana; Motoharu Seiki
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

10.  The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma.

Authors:  Toshiaki Kunimura; Tomohiko Yoshida; Tomoko Sugiyama; Toshio Morohoshi
Journal:  J Gastrointest Cancer       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.